Truveta launches care insights solution to inform pre-launch planning, then follow treatments ...

Truveta has launched a “care insights” solution aimed at closing the information gap between a treatment’s approval and how it actually performs in everyday care. The company will analyze daily updated, de-identified EHR data from more than 140 million U.S. patients, combining billing- and note-derived context to show which patients start therapies, whether prescriptions are filled, device use, and how treatments change over time. De-identified clinical notes are used to add detail on side effects, access barriers, and treatment decisions. Truveta Intelligence, an AI tool, lets users investigate emerging trends in natural language. The approach follows early analysis of Wegovy that showed early users included many new to GLP-1.